Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
Woo
Seung Man
SM
Huh
Chang Hun
CH
Park
Kyung Chan
KC
Youn
Sang Woong
SW
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D012867:Skin / Q000473:pathology
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate